- Home
- OCC vs IPSC Comparison
OCC vs IPSC Comparison
Compare OCC & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- IPSC
- Stock Information
- Founded
- OCC 1983
- IPSC 2019
- Country
- OCC United States
- IPSC United States
- Employees
- OCC N/A
- IPSC N/A
- Industry
- OCC Telecommunications Equipment
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- OCC Industrials
- IPSC Health Care
- Exchange
- OCC Nasdaq
- IPSC Nasdaq
- Market Cap
- OCC 45.3M
- IPSC 47.4M
- IPO Year
- OCC 1996
- IPSC 2021
- Fundamental
- Price
- OCC $4.98
- IPSC $0.63
- Analyst Decision
- OCC
- IPSC Strong Buy
- Analyst Count
- OCC 0
- IPSC 5
- Target Price
- OCC N/A
- IPSC $3.33
- AVG Volume (30 Days)
- OCC 771.7K
- IPSC 1.2M
- Earning Date
- OCC 09-10-2025
- IPSC 08-07-2025
- Dividend Yield
- OCC N/A
- IPSC N/A
- EPS Growth
- OCC N/A
- IPSC N/A
- EPS
- OCC N/A
- IPSC N/A
- Revenue
- OCC $68,999,601.00
- IPSC $114,898,000.00
- Revenue This Year
- OCC N/A
- IPSC $1,590.09
- Revenue Next Year
- OCC N/A
- IPSC N/A
- P/E Ratio
- OCC N/A
- IPSC N/A
- Revenue Growth
- OCC 5.77
- IPSC 8286.72
- 52 Week Low
- OCC $2.02
- IPSC $0.34
- 52 Week High
- OCC $7.00
- IPSC $2.52
- Technical
- Relative Strength Index (RSI)
- OCC 57.45
- IPSC 57.00
- Support Level
- OCC $4.75
- IPSC $0.57
- Resistance Level
- OCC $6.04
- IPSC $0.68
- Average True Range (ATR)
- OCC 0.74
- IPSC 0.04
- MACD
- OCC -0.06
- IPSC 0.01
- Stochastic Oscillator
- OCC 23.75
- IPSC 61.10
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.